Holdings
Merck & Co., Inc.
As of Sep 30, 2026, Merck & Co., Inc. reported 13 positions worth US$820M. Largest: Moderna, Inc., Personalis, Inc. and Kymera Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Moderna, Inc. | 2.31M | US$444M | no change | Sep 30, 2026 |
| Personalis, Inc. | 14M | US$229M | no change | Sep 30, 2026 |
| Kymera Therapeutics, Inc. | 772K | US$86.3M | no change | Sep 30, 2026 |
| Aktis Oncology, Inc. | 953K | US$18.6M | no change | Sep 30, 2026 |
| Eikon Therapeutics, Inc. | 1.67M | US$13.4M | no change | Sep 30, 2026 |
| Entrada Therapeutics, Inc. | 1.74M | US$11M | no change | Sep 30, 2026 |
| Alector, Inc. | 3.55M | US$6.56M | no change | Sep 30, 2026 |
| Sutro Biopharma, Inc. | 272K | US$4.39M | no change | Sep 30, 2026 |
| Evaxion A/S | 1.21M | US$3.98M | new | Sep 30, 2026 |
| Viridian Therapeutics, Inc. | 93,414 | US$1.92M | no change | Sep 30, 2026 |